FibroBiologics Inc (NASDAQ:FBLG) shares, rose in value on Wednesday, June 18, with the stock price down by -4.69% to the previous day’s close as strong demand from buyers drove the stock to $0.72.
Actively observing the price movement in the last trading, the stock closed the session at $0.75, falling within a range of $0.7096 and $0.7775. Referring to stock’s 52-week performance, its high was $7.04, and the low was $0.70. On the whole, FBLG has fluctuated by -21.18% over the past month.
With the market capitalization of FibroBiologics Inc currently standing at about $27.47 million, investors are eagerly awaiting this quarter’s results, scheduled for on 2025-May-14.
Technical indicators serve as essential tools for traders, offering insights into market sentiment and potential price movements. We see that FBLG’s technical picture suggests that short-term indicators denote the stock is a 100% Sell on average. However, medium-term indicators have put the stock in the category of 100% Sell while long-term indicators on average have been pointing out that it is a 100% Sell.
The stock’s technical analysis shows that the price of FBLG currently trading nearly -13.28% and -23.05% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 36.08, while the 7-day volatility ratio is showing 2.56% which for the 30-day chart, stands at 4.97%. Furthermore, FibroBiologics Inc (FBLG)’s beta value is -0.79, and its average true range (ATR) is 0.09.
A comparison of FibroBiologics Inc (FBLG) with its peers suggests the former has fared considerably weaker in the market. FBLG showed an intraday change of -4.69% in last session, and over the past year, it shrunk by -89.90%%.
Data on historical trading for FibroBiologics Inc (NASDAQ:FBLG) indicates that the trading volumes over the past 10 days have averaged 0.28 and over the past 3 months, they’ve averaged 222.22K. According to company’s latest data on outstanding shares, there are 37.74 million shares outstanding.
Nearly 28.35% of FibroBiologics Inc’s shares belong to company insiders and institutional investors own 16.93% of the company’s shares. The data on short interest also indicates that stock shorts accounted for 1.25 million shares as on 2025-05-30, resulting in a short ratio of 6.63. According to the data, the short interest in FibroBiologics Inc (FBLG) stood at 388.00 of shares outstanding as of 2025-05-30; the number of short shares registered in 2025-04-30 reached 1.59 million. The stock has fallen by -64.10% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the FBLG stock heading into the next quarter.
